How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review
- 26 May 2022
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Anti-infective Therapy
- Vol. 20 (8), 1-9
- https://doi.org/10.1080/14787210.2022.2078307
Abstract
Effective treatments for the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic are limited. The virus has evolved strategies to evade the immune system or hijack immune responses to facilitate infection and escape immune surveillance. Mechanistically, SARS-CoV-2 takes advantage of TLR4 and cytokine-induced integrins to promote its entrance into the cell. Furthermore, the activation of pattern recognition receptors (PRR)-mediated signaling pathways is compromised by SARS-CoV-2 non-structural proteins (NSPs), accessory protein open reading frames (ORFs), and structural proteins upon infection, contributing to viral infection and replication. Host factors necessary for cellular protein synthesis, metabolism, and viral replication can also be inhibited by the SARS-CoV-2 proteins. Exploring specific mechanisms would optimize the therapy methods and benefit drug research and development. : We describe pathways and mechanisms by which SARS-CoV-2 evades immune system; these include the mechanisms that operate during virus entry, signaling pathways involved, and processes at RNA and protein levels. : Increased understanding of how viruses interfere with immune responses would provide more evidence for drug development. Drugs targeting conserved viral proteins to inhibit their replication or host factors to enhance immune responses would minimize the impact of virus mutations and prepare for future coronavirus outbreaks.Keywords
Funding Information
- Emergency Key Program of Guangzhou Laboratory (EKPG21-30-1)
This publication has 99 references indexed in Scilit:
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting WuhanEmerging Microbes & Infections, 2020
- Regulation of cGAS- and RLR-mediated immunity to nucleic acidsNature Immunology, 2019
- Type I Interferons: Distinct Biological Activities and Current Applications for Viral InfectionCellular Physiology and Biochemistry, 2018
- The Dual Nature of Type I and Type II InterferonsFrontiers in Immunology, 2018
- Why are RNA virus mutation rates so damn high?PLoS Biology, 2018
- USP13 negatively regulates antiviral responses by deubiquitinating STINGNature Communications, 2017
- Regulation of antiviral T cell responses by type I interferonsNature Reviews Immunology, 2015
- A Virological View of Innate Immune RecognitionAnnual Review of Microbiology, 2012
- Innate immune response to viral infectionCytokine, 2008
- Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome CoronavirusOnline Journal of Public Health Informatics, 2007